lmsdr.org
LMSdr – Working — not wishing — For the Cure
http://lmsdr.org/index.php
Leiomyosarcoma Direct Research Foundation. Working - not wishing - For a Cure. The Founder’s Page. Join Our Patient Registry. Donate Paraffin Tissue Block. Shop for the Cause. Common Drugs for LMS. Start a Tribute Fund. Thank You, Donors. LMSarcoma Direct Research Foundation. LMSdr was created in 2006 to bridge the gap between patients and researchers. Funds LMS specific research. Promotes worthy clinical trials. Advocates for more LMS research. Collaborates with others to support our mission. Contact yo...
thedirectional.com
Ignyta And Its Secondary Offering | The Directional, An Online Newsletter
https://thedirectional.com/2016/04/28/ignyta-and-its-secondary-offering
Ignyta And Its Secondary Offering. Posted by P I A. April 28, 2016. Ignyta (RXDX) is an intriguing biotech firm. Its technologies are showing amazing efficacy at treating cancer, which is obviously laudable. Like much of the industry, however, its share price exhibits volatility, and its ability to meet requisite fiscal needs is an ongoing concern to those who would risk capital. With a somewhat predictable sale of stock, the corporation could now be of interest to investors as it trades lower. The finan...